John Crowley, a featured Keynote at this year's Molecular Medicine Tri-Conference, is the inspiration for a new film which will find its way onto the big screen January 22.
Needham, Mass. (PRWEB) November 11, 2009 -- Cambridge Healthtech Institute's (CHI) flagship event, the Molecular Medicine Tri-Conference (February 3-5, 2010) will feature inspirational Keynote John F. Crowley, Founder, Novazyme Pharmaceuticals, Inc.
Mr. Crowley, a Harvard educated businessman, created and built a pharmaceutical company devoted entirely to finding a cure for Pompe disease. He will detail his journey through the labyrinth of scientific and business fronts, which lead up to a first-round clinical trial.
In 1998, two of John Crowley's three children were diagnosed with Pompe disease, a rare and fatal neuromuscular disorder that affects only several thousand children worldwide. After his children were given months to live, and being told there was nothing to be done, John began his incredible journey to find a cure for this fatal disease.
Originally dismissed by virtually all in the biotechnology industry as having no chance of success, Novazyme quickly grew to a 100-person company. Crowley, as CEO of Novazyme, commuted weekly from his home in Princeton, NJ, to Oklahoma City. He raised over $27 million in venture capital on Wall Street for Novazyme in less than a year. Within 18 months of his helping Dr. Canfield to start Novazyme, he agreed for Novazyme to be acquired by Genzyme Corporation, the world's third largest biotechnology company, for a price of $225 million, one of the largest amounts ever paid for a pre-clinical drug development company in biotechnology history.
John Crowley's remarkable story will be released in a film starring Harrison Ford and Brendan Fraiser in January 2010, Extraordinary Measures. An uplifting, inspirational drama, it is based on a Wall Street Journa
Copyright©2009 Vocus, Inc.
All rights reserved